Reconciling quality measurement with financial risk adjustment in health plans.

Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.

Reconciling quality measurement with financial risk adjustment in health plans.

Jt Comm J Qual Improv. 2000 Mar;26(3):137-46. Unique Identifier : AIDSLINE MED/20173923
Dudley RA; Bowers LV; Luft HS; Department of Medicine, University of California, San Francisco; 94118, USA. adudley@itsa.uscf.edu

Abstract: BACKGROUND: Initiatives to improve quality measurement (QM) and to create systems for financial risk adjustment (RA) have developed in response to concerns about price competition's threat to quality and stimulation of risk selection. QM is designed to help purchasers identify best plans, to aid plans in their selection of providers, to facilitate quality improvement by plans and providers, and to assist patients faced with choices among plans and providers. The goal of RA is to eliminate incentives for plans and providers to avoid sick, high-cost patients in favor of healthy, low-cost patients. CONFLICTS BETWEEN QM AND RA: For QM it is often necessary to identify all patients with a particular condition, and many quality measures involve intervening on patients early in the course of their disease. Identifying patients through utilization decisions (for example, identifying patients with depression through receipt of an antidepressant prescription) may bias QM. For RA, the focus is on the highest-cost patients, and patient capture through resource utilization is more likely to be appropriate. DISCUSSION: Achieving QM and RA depends on improving information systems and patient identification processes and developing standard definitions for important variables. QM and RA could both be improved, and the conflicts between them reduced, if they were based more on detailed clinical data, if consensus definitions of quality of care for specific diagnoses could be achieved, if the number of QM measures that target acute and chronic care (versus preventive care) were increased, and if information systems were enhanced.

Keywords: JOURNAL ARTICLE Antidepressive Agents/ECONOMICS/THERAPEUTIC USE Breast Neoplasms/THERAPY Comparative Study Costs and Cost Analysis Cystic Fibrosis/THERAPY Data Collection Depression/DRUG THERAPY Female Heart Failure, Congestive/THERAPY Human HIV Infections/THERAPY Male *Managed Care Programs/ECONOMICS/STANDARDS Medical Records *Quality Assurance, Health Care Retrospective Studies *Risk Adjustment *Risk Sharing, Financial Support, Non-U.S. Gov't United States

000630
A0061975

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .